112 related articles for article (PubMed ID: 1477265)
1. Chitosan beads and granules for oral sustained delivery of nifedipine: in vitro studies.
Chandy T; Sharma CP
Biomaterials; 1992; 13(13):949-52. PubMed ID: 1477265
[TBL] [Abstract][Full Text] [Related]
2. Chitosan matrix for oral sustained delivery of ampicillin.
Chandy T; Sharma CP
Biomaterials; 1993 Oct; 14(12):939-44. PubMed ID: 8268386
[TBL] [Abstract][Full Text] [Related]
3. Effect of liposome-albumin coatings on ferric ion retention and release from chitosan beads.
Chandy T; Sharma CP
Biomaterials; 1996 Jan; 17(1):61-6. PubMed ID: 8962949
[TBL] [Abstract][Full Text] [Related]
4. Drug release behavior of beads and microgranules of chitosan.
Gupta KC; Ravi Kumar MN
Biomaterials; 2000 Jun; 21(11):1115-9. PubMed ID: 10817263
[TBL] [Abstract][Full Text] [Related]
5. Preparation and in vitro evaluation of chitosan microgranules with clotrimazole.
Szymańska E; Winnicka K
Acta Pol Pharm; 2012; 69(3):509-13. PubMed ID: 22594265
[TBL] [Abstract][Full Text] [Related]
6. Biodegradable chitosan matrix for the controlled release of steroids.
Chandy T; Sharma CP
Biomater Artif Cells Immobilization Biotechnol; 1991; 19(4):745-60. PubMed ID: 1810408
[TBL] [Abstract][Full Text] [Related]
7. Nifedipine loaded chitosan microspheres prepared by emulsification phase-separation.
Dhawan S; Singla AK
Biotech Histochem; 2003 Oct; 78(5):243-54. PubMed ID: 14989642
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of iron-crosslinked chitosan succinate and iron-crosslinked hydroxamated chitosan succinate and their in vitro evaluation as potential matrix materials for oral theophylline sustained-release beads.
Aiedeh K; Taha MO
Eur J Pharm Sci; 2001 May; 13(2):159-68. PubMed ID: 11297900
[TBL] [Abstract][Full Text] [Related]
9. The controlled release of a drug from biodegradable chitosan gel beads.
Kofuji K; Ito T; Murata Y; Kawashima S
Chem Pharm Bull (Tokyo); 2000 Apr; 48(4):579-81. PubMed ID: 10783085
[TBL] [Abstract][Full Text] [Related]
10. Development of chitosan/polyethylene vinyl acetate co-matrix: controlled release of aspirin-heparin for preventing cardiovascular thrombosis.
Vasudev SC; Chandy T; Sharma CP
Biomaterials; 1997 Mar; 18(5):375-81. PubMed ID: 9061177
[TBL] [Abstract][Full Text] [Related]
11. Controlled release of nifedipine from gelatin microspheres and microcapsules: in vitro kinetics and pharmacokinetics in man.
Leucuţa SE
J Microencapsul; 1990; 7(2):209-17. PubMed ID: 2329447
[TBL] [Abstract][Full Text] [Related]
12. Nifedipine loaded chitosan microspheres: characterization of internal structure.
Singla AK; Sharma ML; Dhawan S
Biotech Histochem; 2001 Jul; 76(4):165-71. PubMed ID: 11549129
[TBL] [Abstract][Full Text] [Related]
13. Rate-controlling biopolymer membranes as transdermal delivery systems for nifedipine: development and in vitro evaluations.
Thacharodi D; Rao KP
Biomaterials; 1996 Jul; 17(13):1307-11. PubMed ID: 8805978
[TBL] [Abstract][Full Text] [Related]
14. Chitosan/calcium alginate microcapsules for intestinal delivery of nitrofurantoin.
Hari PR; Chandy T; Sharma CP
J Microencapsul; 1996; 13(3):319-29. PubMed ID: 8860687
[TBL] [Abstract][Full Text] [Related]
15. Preparation and in vitro evaluation of chitosan matrices for colonic controlled drug delivery.
Zambito Y; Di Colo G
J Pharm Pharm Sci; 2003; 6(2):274-81. PubMed ID: 12935439
[TBL] [Abstract][Full Text] [Related]
16. Preparation and characterization of melatonin-loaded stearyl alcohol microspheres.
Lee BJ; Choe JS; Kim CK
J Microencapsul; 1998; 15(6):775-87. PubMed ID: 9818955
[TBL] [Abstract][Full Text] [Related]
17. Design and evaluation of chitosan/ethylcellulose mucoadhesive bilayered devices for buccal drug delivery.
Remuñán-López C; Portero A; Vila-Jato JL; Alonso MJ
J Control Release; 1998 Nov; 55(2-3):143-52. PubMed ID: 9795035
[TBL] [Abstract][Full Text] [Related]
18. Development of poly(Lactic acid)/chitosan co-matrix microspheres: controlled release of taxol-heparin for preventing restenosis.
Chandy T; Rao GH; Wilson RF; Das GS
Drug Deliv; 2001; 8(2):77-86. PubMed ID: 11400866
[TBL] [Abstract][Full Text] [Related]
19. Chitosan salts as nasal sustained delivery systems for peptidic drugs.
Cerchiara T; Luppi B; Bigucci F; Zecchi V
J Pharm Pharmacol; 2003 Dec; 55(12):1623-7. PubMed ID: 14738587
[TBL] [Abstract][Full Text] [Related]
20. Development and in vitro evaluation of chitosan-based transdermal drug delivery systems for the controlled delivery of propranolol hydrochloride.
Thacharodi D; Rao KP
Biomaterials; 1995 Jan; 16(2):145-8. PubMed ID: 7734649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
